Dermata Therapeutics, Inc. (DRMA)
NASDAQ·Healthcare·Biotechnology
$0.76
—
Mkt Cap $3.74M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+689.5%
Consensus $6.00 vs current $0.76
NASDAQ·Healthcare·Biotechnology
$0.76
—
Mkt Cap $3.74M
No recent rating data.
Price Target (1 analysts)
$6.00
Range $6.00 – $6.00
+689.5%
Consensus $6.00 vs current $0.76